• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Adv Res . Genomic characterization of SARS-CoV-2 in Egypt

tetano

Editor, Senior Moderator
J Adv Res


. 2020 Nov 26.
doi: 10.1016/j.jare.2020.11.012. Online ahead of print.
Genomic characterization of SARS-CoV-2 in Egypt


Abdel-Rahman N Zekri[SUP] 1 [/SUP], Khaled Easa Amer[SUP] 2 [/SUP], Mohammed M Hafez[SUP] 1 [/SUP], Zeinab K Hassan[SUP] 1 [/SUP], Ola S Ahmed[SUP] 1 [/SUP], Hany K Soliman[SUP] 1 [/SUP], Abeer A Bahnasy[SUP] 3 [/SUP], Wael Abdel Hamid[SUP] 4 [/SUP], Ahmad Gad[SUP] 4 [/SUP], Mahmoud Ali[SUP] 2 [/SUP], Wael Hassan[SUP] 2 [/SUP], Mahmoud Samir[SUP] 2 [/SUP], Ahmad Raouf[SUP] 2 [/SUP], Ayman A Khattab[SUP] 2 [/SUP], Mona Salah El Din Hamdy[SUP] 5 [/SUP], May Sherif Soliman[SUP] 5 [/SUP], Maha Hamdi El Sissy[SUP] 5 [/SUP], Sara Mohamed El Khateeb[SUP] 5 [/SUP], Moushira Hosny Ezzelarab[SUP] 5 [/SUP], Lamiaa A Fathalla[SUP] 6 [/SUP], Mohamed Abouelhoda[SUP] 7 [/SUP]



Affiliations

Abstract

Introduction: The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread throughout the globe, causing a pandemic. In Egypt over 96,108 individuals were infected so far.
Objective: In the present study, the objective is to perform a complete genome sequence of SAR-CoV2 isolated from Egyptian coronavirus disease (COVID-19) patients.
Methods: Nasopharyngeal swabs were collected from 61 COVID-19 patients who attended at National Cancer Institute, Kasr Al-Aini Hospital and the army hospital. Viral RNA was extracted and whole genomic sequencing was conducted using Next Generation Sequencing.
Results: In all cases, the sequenced virus has at least 99% identity to the reference Wuhan 1. The sequence analysis showed 204 distinct genome variations including 114 missense mutations, 72 synonymous mutations, 1 disruptive in-frame deletion, 7 downstream gene mutations, 6 upstream gene mutations, 3 frame-shift deletions, and 1 in-frame deletion. The most dominant clades were G/GH/GR/O and the dominant type is B.
Conclusion: The whole genomic sequence of SARS-CoV2 showed 204 variations in the genomes of the Egyptian isolates, where the Asp614Gly (D614G) substitution is the most common among the samples (60/61). So far, there were no strikingly variations specific to the Egyptian population, at least for this set of samples.

Keywords: Next generation sequencing; Sars-CoV2; real time PCR.
 
Back
Top Bottom